000			03021cam a2200457M 4500
001			9781315102856
003			FlBoTFG
005			20220724194306.0
006			m o d
007			cr |n|||||||||
008			191209s2019 flu o 000 0 eng d
040			_aOCoLC-P _beng _cOCoLC-P
020			_a9781351593335 _q(electronic bk.)
020			_a1351593331 _q(electronic bk.)
020			_a9781315102856 _q(electronic bk.)
020			_a1315102854 _q(electronic bk.)
020			_a9781351593328 _q(electronic bk. : EPUB)
020			_a1351593323 _q(electronic bk. : EPUB)
020			_a9781351593311 _q(electronic bk. : Mobipocket)
020			_a1351593315 _q(electronic bk. : Mobipocket)
020			_z1138103306
020			_z9781138103306
035			_a(OCoLC)1134149124
035			_a(OCoLC-P)1134149124
050		4	_aRS200
072		7	_aMED _x071000 _2bisacsh
072		7	_aMMG _2bicssc
082	0	4	_a615.19 _223
100	1		_aNiazi, Sarfaraz, _d1949-
245	1	0	_aHandbook of pharmaceutical manufacturing formulations. _nVolume four, _pSemisolid products / _cSarfaraz K. Niazi.
250			_aThird edition.
260			_aBoca Raton : _bCRC PRESS, _c2019.
300			_a1 online resource
520			_aThe Handbook of Pharmaceutical Manufacturing Formulations, Third Edition: Volume Four, Semisolid Products is an authoritative and practical guide to the art and science of formulating drugs for commercial manufacturing. With thoroughly revised and expanded content, thisfourth volume of a six-volume set, compiles data from FDA and EMA new drug applications, patents and patent applications, and other sources of generic and proprietary formulations including author's own experience, to cover the broad spectrum of cGMP formulations and issues in using these formulations in a commercial setting. A must-have collection for pharmaceutical manufacturers, educational institutions, and regulatory authorities, this is an excellent platform for drug companies to benchmark their products and for generic companies to formulate drugs coming off patent. Features: Largest source of authoritative and practical formulations, cGMP compliance guidance and self-audit suggestions Differs from other publications on formulation science in that it focuses on readily scalable commercial formulations that can be adopted for cGMP manufacturing Tackles common difficulties in formulating drugs and presents details on stability testing, bioequivalence testing, and full compliance with drug product safety elements Written by a well-recognized authority on drug and dosage form development including biological drugs and alternative medicines
588			_aOCLC-licensed vendor bibliographic record.
650		0	_aDrugs _xDosage forms.
650		7	_aMEDICAL / Pharmacology _2bisacsh
856	4	0	_3Read Online _uhttps://www.taylorfrancis.com/books/9781315102856
856	4	2	_3OCLC metadata license agreement _uhttp://www.oclc.org/content/dam/oclc/forms/terms/vbrl-201703.pdf
942			_2lcc _cEBK
999			_c15923 _d15923